---
layout: post
title: "Disseminated Coccidioidomycosis: Developing Drugs for Treatment; Draft Guidance for Industry; Availability"
date: 2026-02-04 21:49:21 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18002
original_published: 2025-09-17 00:00:00 +0000
significance: 8.00
---

# Disseminated Coccidioidomycosis: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 17, 2025 00:00 UTC
**Document Number:** 2025-18002

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Disseminated Coccidioidomycosis: Developing Drugs for Treatment." The purpose of this draft guidance is to assist sponsors in the clinical development of drugs for the treatment of disseminated coccidioidomycosis caused by Coccidioides species (i.e., C. immitis and C. posadasii).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/17/2025-18002/disseminated-coccidioidomycosis-developing-drugs-for-treatment-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2025-18002

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
